Furthermore, studies have shown that B cells and B cell receptor-associated kinases, such as BTK, function in the microenvironment of squamous cell carcinoma and pancreatic cancer, so targeting B cells or B cell receptor-associated kinases may have more potent anticancer activity than B cell malignancies [44]. The gene discussed is BTK; the disease is squamous cell carcinoma.